Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2013. The document serves as a notification of transactions involving Directors and Persons Discharging Managerial Responsibility regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by several executives on May 10, 2013, through the Company's ShareReward Plan. The purchase price was 1,662.09 pence per Ordinary Share. Transactions included both personal contributions and matching company contributions.
- Sir Andrew Witty: Acquired 8 shares (personal) and 8 shares (company match).
- Mr S Dingemans: Acquired 8 shares (personal) and 8 shares (company match).
- Mr S M Bicknell: Acquired 8 shares (personal) and 8 shares (company match).
- Mr R G Connor: Acquired 8 shares (personal) and 8 shares (company match).
- Mr D S Redfern: Acquired 8 shares (personal) and 8 shares (company match).
- Ms C Thomas: Acquired 8 shares (personal) and 8 shares (company match).
- Mr P C Thomson: Acquired 7 shares (personal) and 7 shares (company match).
- Dr P J T Vallance: Acquired 7 shares (personal) and 7 shares (company match).
- Ms E Walmsley: Acquired 8 shares (personal) and 8 shares (company match).
- Mrs V A Whyte: Acquired 8 shares (personal) and 8 shares (company match).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of share transactions in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Executives purchased shares at 1,662.09 pence per share on May 10, 2013.
- Transactions were executed via the ShareReward Plan, involving both personal and company-matched contributions.
- The total number of shares acquired per executive ranged from 14 to 16 shares (combining personal and matched portions).
- The notification was signed by Victoria Whyte, Company Secretary, on May 13, 2013.